文献速递艾滋病与性传播感染

REPRIEVE试验:符合一级预防条件的HIV感染者心血管风险与健康状况

Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.
PubMed 文献 · Clin Infect Dis · 2021-01-01

REPRIEVE随机试验纳入7382名HIV感染者,评估其动脉粥样硬化心血管病预测风险(PCE)与Life's Simple 7(LS7)健康评分。中位PCE风险为4.5%,但LS7健康评分普遍较差,仅0.3%达到7/7理想指标。无论PCE高低,不良饮食和体力活动模式均常见,提示生活方式干预在HIV感染者心血管预防中具有独立重要作用。

要点

  • HIV感染者中位PCE风险4.5%,但LS7健康评分普遍较差。
  • 仅0.3%参与者达到7/7理想LS7指标,90%不足5个理想指标。
  • 不良饮食和体力活动模式在所有PCE风险类别中均常见。

核心结论

  • REPRIEVE参与者中LS7评估的心血管健康状况普遍较差,且与PCE风险评分无关,提示生活方式干预在HIV感染者心血管预防中具有关键且独立的作用。

研究设计与样本

  • 全球REPRIEVE随机试验纳入7382名HIV感染者,其中31%为女性,45%为黑人,分析其人口学、HIV特征与PCE预测风险及LS7健康评分的关系。

主要发现

  • 中位PCE风险评分为4.5%(Q1,Q3:2.2,7.2),29%的PCE评分<2.5%,9%的评分>10%。
  • PCE评分与已知心血管危险因素密切相关,与免疫功能和HIV参数的关联较弱(风险评分差异<1%)。
  • 中位LS7评分为9分(Q1,Q3:7,10),满分14分;仅24名参与者(0.3%)达到7/7理想组分,36%有≤2个理想组分,90%有<5个理想组分。
  • LS7分布不随年龄或生理性别变化,但理想健康状况在低社会人口指数国家和亚洲人中更常见。
  • 不良饮食和体力活动模式在所有PCE评分类别中均可见,包括最低风险类别。

临床怎么用

  • 对符合条件的HIV感染者,除常规治疗外应重视生活方式干预以改善心血管结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In addition to traditional cardiovascular (CV) risk factors, antiretroviral therapy, lifestyle, and human immunodeficiency virus (HIV)-related factors may contribute to future CV events in persons with HIV (PWH). METHODS: Among participants in the global REPRIEVE randomized trial, we characterized demographics and HIV characteristics relative to ACC/AHA pooled cohort equations (PCE) for atherosclerotic CV disease predicted risk and CV health evaluated by Life's Simple 7 (LS7; includes smoking, diet, physical activity, body mass index, blood pressure, total cholesterol, and glucose). RESULTS: Among 7382 REPRIEVE participants (31% women, 45% Black), the median PCE risk score was 4.5% (lower and upper quartiles Q1, Q3: 2.2, 7.2); 29% had a PCE score <2.5%, and 9% scored above 10%. PCE score was related closely to known CV risk factors and modestly (<1% difference in risk score) to immune function and HIV parameters. The median LS7 score was 9 (Q1, Q3: 7, 10) of a possible 14. Only 24 participants (0.3%) had 7/7 ideal components, and 36% had ≤2 ideal components; 90% had <5 ideal components. The distribution of LS7 did not vary by age or natal sex, although ideal health was more common in low sociodemographic index countries and among Asians. Poor dietary and physical activity patterns on LS7 were seen across all PCE scores, including the lowest risk categories. CONCLUSIONS: Poor CV health by LS7 was common among REPRIEVE participants, regardless of PCE. This suggests a critical and independent role for lifestyle interventions in conjunction with conventional treatment to improve CV outcomes in PWH. Clinical Trials Registration: NCT02344290. AIDS Clinical Trials Group study number: A5332.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Douglas PS, Umbleja T, Bloomfield GS, et al. Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial. Clin Infect Dis. 2021. PMID: 34134131. doi:10.1093/cid/ciab552

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。